ASCO 2024: Telehealth as effective as in-person care for early palliative treatment in patients with advanced lung cancer
New research reinforces telehealth delivery of palliative care as an effective alternative to in-person visits…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
ASCO 2024: CAR T-cell therapy shows promise in patients with central nervous system lymphoma
A CAR T-cell therapy approved for patients with large B cell lymphoma has produced positive…
ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung cancer
Results from a new study demonstrate that consolidation therapy – or treatment given for a…
ASCO 2024: Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-mutated NSCLC
Osimertinib improves progression-free survival in patients with unresectable stage III EGFR-mutated NSCLC that has been…
ASCO 2024: Dual immunotherapy treatment before surgery, rather than after, improves outcomes in melanoma patients
Neoadjuvant immunotherapy given for stage III melanoma, followed by adjuvant therapy only if there is…
ASCO 2024: Lymphadenectomy may not be needed for patients with advanced ovarian cancer
Some people with advanced epithelial ovarian cancer may safely avoid having their lymph nodes removed…
ASCO 2024: Improved progression-free survival in PD-L1-positive hormone receptor-positive, HER2-negative breast cancer
In patients with metastatic hormone receptor (HR)-positive/HER2-negative breast cancer unselected by PD-L1 status, adding the…
ASCO 2024: Drug targeting protein involved in control of immune response produces encouraging results in glioblastoma
A drug that targets a protein involved in regulating the immune response might be promising…
ASCO 2024: Experimental therapy shows promise in pancreatic cancer clinical trial
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center, USA, reported promising preliminary findings based on…
ENDO 2024: Almost 20% of breast cancer survivors may experience excess weight gain
Almost one out of five breast cancer survivors may experience weight gain of more than…